Stem Cell-Based Drug Discovery and Disease Modeling

Stem cell technologies have transformed biomedical research by providing advanced platforms for understanding diseases and developing new medicines. This area focuses on the use of stem cells in drug discovery, toxicity testing, and disease modeling. Researchers will discuss how patient-derived stem cells and organoid models help recreate disease conditions in the laboratory. The topic highlights applications in personalized medicine and targeted therapeutic development. Experts will explore how stem cell-based models can improve the efficiency and accuracy of drug screening processes. Discussions will include advancements in organ-on-chip technologies and precision medicine approaches. This topic provides opportunities to explore the role of stem cells in accelerating pharmaceutical innovation.

  • Stem cell-based disease models
  • Drug screening platforms
  • Organoid technologies

    Related Conference of Stem Cell-Based Drug Discovery and Disease Modeling

    September 24-25, 2026

    7th Annual summit on Cell Signaling and Cancer Therapy

    Paris, France
    December 03-04, 2026

    19th World Congress on Stem Cell Research

    Madrid, Spain

    Stem Cell-Based Drug Discovery and Disease Modeling Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in